The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning

Seshadri, Sudha; De Erausquin, Gabriel A.; Snyder, Heather; Hosseini, Akram A.; Brugha, Traolach S.; CNS SARS‐CoV‐2 Consortium; Carrillo, María

dc.contributor.author	De Erausquin, Gabriel A.
dc.contributor.author	Snyder, Heather
dc.contributor.author	Carrillo, María
dc.contributor.author	Hosseini, Akram A.
dc.contributor.author	Brugha, Traolach S.
dc.contributor.author	Seshadri, Sudha
dc.contributor.author	CNS SARS‐CoV‐2 Consortium
dc.date.accessioned	2021-01-25T18:52:59Z
dc.date.available	2021-01-25T18:52:59Z
dc.date.issued	2020
dc.identifier.uri	https://hdl.handle.net/20.500.12866/8953
dc.description.abstract	Introduction: The increasing evidence of SARS‐CoV‐2 impact on the central nervous system (CNS) raises key questions on its impact for risk of later life cognitive decline, Alzheimer's disease (AD), and other dementia. Methods: The Alzheimer's Association and representatives from more than 30 countries—with technical guidance from the World Health Organization—have formed an international consortium to study the short‐and long‐term consequences of SARS‐CoV‐2 on the CNS—including the underlying biology that may contribute to AD and other dementias. This consortium will link teams from around the world covering more than 22 million COVID‐19 cases to enroll two groups of individuals including people with disease, to be evaluated for follow‐up evaluations at 6, 9, and 18 months, and people who are already enrolled in existing international research studies to add additional measures and markers of their underlying biology. Conclusions: The increasing evidence and understanding of SARS‐CoV‐2's impact on the CNS raises key questions on the impact for risk of later life cognitive decline, AD, and other dementia. This program of studies aims to better understand the long‐term consequences that may impact the brain, cognition, and functioning—including the underlying biology that may contribute to AD and other dementias.	en_US
dc.language.iso	eng
dc.publisher	Wiley
dc.relation.ispartofseries	Alzheimer's and Dementia
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject	cognitive decline	en_US
dc.subject	COVID-19	en_US
dc.subject	neuropsychiatry	en_US
dc.subject	SARS-CoV-2	en_US
dc.title	The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning	en_US
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	https://doi.org/10.1002/alz.12255
dc.subject.ocde	https://purl.org/pe-repo/ocde/ford#3.02.25
dc.relation.issn	1552-5279